Tara, a chatbot that matches patients to clinical trials

Cancer patients hoping to be part of a clinical trial for a new therapy often have difficulty locating and applying for such trials, while the contract research organizations (CROs) managing the trials often have difficulty recruiting patients.

Belong.Life, an Israeli-founded group of patient communities and care platforms, is making clinical trial matching and recruitment easier with the launch of Tara, a conversational AI cancer clinical trial matching platform.

Tara is a chatbot that conversationally requests essential information including diagnosis, cancer type, mutation and treatment history. It  can even scan relevant medical files to collect comprehensive information to assist with clinical trial matching.

Read the full article >

More Articles

Dave AI on TIME’s Best Inventions of 2024 List

Dave AI is one of groundbreaking innovations recognized in TIME’s ‘Best Inventions of 2024 …

Belong Honored as a Top Oncology Solution Provider Transforming Healthcare

Belong.Life is one of the “Starts Us Insights” 8 top oncology solutions impacting the…

The Best Inventions of 2024

At times when doctors aren’t available, people with cancer can turn to Dave — an…
Skip to content